Outset Medical
85 hedge funds and large institutions have $1.76B invested in Outset Medical in 2020 Q3 according to their latest regulatory filings, with 85 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
5.88% more ownership
Funds ownership: 0% → 5.88% (+5.9%)
Top Buyers
| 1 |
WP
Warburg Pincus
New York
|
+$491M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$348M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$251M |
| 4 |
DCP
D1 Capital Partners
New York
|
+$251M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$157M |
Top Sellers
OM Hedge Fund Activity: Q3 2020 in Review
85 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Outset Medical (OM) for Q3 2020, worth a combined $1.76B.
Buyers outnumbered sellers: 85 funds opened new OM positions and 0 closed out — a net gain of 85 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Warburg Pincus, opening a new position worth an estimated $491M.
- 85 institutional investors held Outset Medical (OM) as of Q3 2020, up from 0 in Q2 2020.
- Funds reported $1.76B of Outset Medical stock for Q3 2020.
- 85 funds opened new Outset Medical positions in Q3 2020 and 0 closed out, a net change of +85 holders.
- The largest Outset Medical buyer in Q3 2020 was Warburg Pincus, an estimated $491M added.
Based on aggregated 13F filings for Q3 2020.